1. Home
  2. TYRA vs GCI Comparison

TYRA vs GCI Comparison

Compare TYRA & GCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • GCI
  • Stock Information
  • Founded
  • TYRA 2018
  • GCI 1997
  • Country
  • TYRA United States
  • GCI United States
  • Employees
  • TYRA N/A
  • GCI N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • GCI Newspapers/Magazines
  • Sector
  • TYRA Health Care
  • GCI Consumer Discretionary
  • Exchange
  • TYRA Nasdaq
  • GCI Nasdaq
  • Market Cap
  • TYRA 556.4M
  • GCI 549.7M
  • IPO Year
  • TYRA 2021
  • GCI N/A
  • Fundamental
  • Price
  • TYRA $10.09
  • GCI $3.71
  • Analyst Decision
  • TYRA Strong Buy
  • GCI Buy
  • Analyst Count
  • TYRA 6
  • GCI 3
  • Target Price
  • TYRA $30.50
  • GCI $5.70
  • AVG Volume (30 Days)
  • TYRA 281.8K
  • GCI 2.0M
  • Earning Date
  • TYRA 05-08-2025
  • GCI 05-01-2025
  • Dividend Yield
  • TYRA N/A
  • GCI N/A
  • EPS Growth
  • TYRA N/A
  • GCI N/A
  • EPS
  • TYRA N/A
  • GCI 0.36
  • Revenue
  • TYRA N/A
  • GCI $2,445,127,000.00
  • Revenue This Year
  • TYRA N/A
  • GCI N/A
  • Revenue Next Year
  • TYRA N/A
  • GCI N/A
  • P/E Ratio
  • TYRA N/A
  • GCI $10.33
  • Revenue Growth
  • TYRA N/A
  • GCI N/A
  • 52 Week Low
  • TYRA $6.42
  • GCI $2.55
  • 52 Week High
  • TYRA $29.60
  • GCI $5.93
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 52.97
  • GCI 63.51
  • Support Level
  • TYRA $8.80
  • GCI $3.08
  • Resistance Level
  • TYRA $10.56
  • GCI $3.32
  • Average True Range (ATR)
  • TYRA 0.75
  • GCI 0.19
  • MACD
  • TYRA 0.06
  • GCI 0.04
  • Stochastic Oscillator
  • TYRA 58.90
  • GCI 98.68

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About GCI Gannett Co. Inc.

Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.

Share on Social Networks: